Jiujie Cui, Liwei Wang, Jingyu Cao, Ming Quan, Wei Li, Mei Zhang, Da Li, Yingzhi Lu, Xiujuan Qu, Jun Wu, Guoliang Yao, Zhiwei Li. "Preliminary results of ALTER-PA-001 trial: A multicenter, open-label, randomized, phase II trial of anlotinib and benmelstobart in combination with AG versus AG as first-line treatment for metastatic pancreatic cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.719